DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ablavar (Gadofosveset Trisodium) - Published Studies

 
 



Ablavar Related Published Studies

Well-designed clinical trials related to Ablavar (Gadofosveset)

Contrast-enhanced whole-heart MR coronary angiography at 3.0 T using the intravascular contrast agent gadofosveset. [2009.07]

Safety and efficacy of gadofosveset-enhanced MR angiography for evaluation of pedal arterial disease: multicenter comparative phase 3 study. [2008.01]

Other research related to Ablavar (Gadofosveset)

Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium. [2011.02]

CMR assessment of endothelial damage and angiogenesis in porcine coronary arteries using gadofosveset. [2011.01.26]

Diffusion magnetic resonance imaging with gadofosveset trisodium as a negative contrast agent for lymph node metastases assessment. [2011.01]

Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison. [2010.08]

Contrast-enhanced whole-heart coronary MRA using Gadofosveset 3.0 T versus 1.5 T. [2010.07]

Gadofosveset-enhanced magnetic resonance imaging of human carotid atherosclerotic plaques: a proof-of-concept study. [2010.05]

First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium. [2009.10]

Thoracic and abdominal MRA with gadofosveset: influence of injection rate on vessel signal and image quality. [2009.08]

Gadofosveset-enhanced MR angiography of carotid arteries: does steady-state imaging improve accuracy of first-pass imaging? Comparison with selective digital subtraction angiography. [2009.05]

A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease. [2008.02]

Gadofosveset-enhanced magnetic resonance angiography. [2008]

Whole-heart coronary magnetic resonance angiography with MS-325 (Gadofosveset). [2007.11]

Other possibly related research studies

High Spatial Resolution and High Contrast Visualization of Brain Arteries and Veins: Impact of Blood Pool Contrast Agent and Water-Selective Excitation Imaging at 3T. [2010.08.27]

Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging. [2010.03]

[Nephrogenic systemic fibrosis] [2009.10]

Increased volume of coverage for abdominal contrast-enhanced MR angiography with two-dimensional autocalibrating parallel imaging: initial experience at 3.0 Tesla. [2009.11]

Human brain tumor imaging with a protein-binding MR contrast agent: initial experience. [2010.01]

MR angiographic follow-up of intracranial aneurysms treated with detachable coils: evaluation of a blood-pool contrast medium. [2009.09]

Dynamic magnetic resonance angiography of the arteries of the hand. A comparison between an extracellular and an intravascular contrast agent. [2009.02]

Intravascular contrast agent T1 shortening: fast T1 relaxometry in a carotid volunteer study. [2008.09]

Current status of renal artery magnetic resonance imaging: theoretical and practical considerations and the potential role of blood-pool contrast agents. [2007.03]

Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model. [2007.07]

Imaging the whole body atherosclerosis: high resolution magnetic resonance angiography using blood-pool agent. Initial clinical experience. [2007.06]

[Diagnostic performance of contrast-enhanced MR angiography of the aortoiliac arteries with the blood pool agent Vasovist: initial results in comparison to intra-arterial DSA] [2007.04]

Combined respiratory and cardiac triggering improves blood pool contrast-enhanced pediatric cardiovascular MRI. [2011.12]

High-resolution MRI of carotid plaque with a neurovascular coil and contrast-enhanced MR angiography: one-stop shopping for the comprehensive assessment of carotid atherosclerosis. [2011.05]

Morphological and functional 3-Tesla magnetic resonance imaging of saphenous vein coronary artery bypass grafts. [2011.04]

Imaging patients with kidney disease: how do we approach contrast-related toxicity? [2011.03]

High spatial resolution and high contrast visualization of brain arteries and veins: impact of blood pool contrast agent and water-selective excitation imaging at 3T. [2010.12]

Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent. [2011.02]

Diagnosis of popliteal venous entrapment syndrome by magnetic resonance imaging using blood-pool contrast agents. [2011.02]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012